RAPS Highlights

 

 

 

 

17 January 2022 | By Joanne S. Eglovitch
Former commissioners, Woodcock dissect pandemic response, future challenges at FDA

A panel of former US Food and Drug Administration (FDA) commissioners, moderated by Acting FDA Commissioner Janet Woodcock, addresse...

17 January 2022 | By Jeff Craven
GAO tasks FDA with developing agency-wide workforce plan for medical product staff

Centers within the US Food and Drug Administration (FDA) are using the flexibility in hiring and pay requirements afforded by the 2...

17 January 2022 | By Joanne S. Eglovitch
Recon: Pfizer to increase COVID-19 antiviral output with French deal; Unilever signals pursuit of GSK consumer arm

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.

14 January 2022 | By Michael Mezher
This Week at FDA: User fee update, Califf nomination, and more

Welcome to another edition of This Week at FDA! There were some major developments this week with potential ramifications for FDA in...

14 January 2022 | By Jeff Craven
COVID-19 vaccine tracker

Updated 14 January to include new information on vaccines from Pfizer/BioNTech, Moderna, AstraZeneca, Gamaleya Research Institute,...